We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use ÌìÃÀÓ°Ôº, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Revised guidance on veterinary medicines containing controlled drugs (CDs) including who can witness their destruction.
Ectoparasiticide veterinary medicinal products and reporting adverse events.
Increase in suspected adverse event reports following use of Genta-Equine 100 mg/ml Solution for Injection for Horses.
Antimicrobial Resistance Surveillance Co-ordinator, working on the UK's programmes of AMR surveillance in animals.
Vaccination of birds against high pathogenicity avian influenza joint statement from the avian influenza vaccination taskforce.
These published standards relate to a number of KPIs in the VMD Deliverables and KPI document.
Canada and UK Trade Continuity Agreement enters into force
Reminder of the updated guidance on blood and blood products for animal treatment.
Increase in suspected adverse event reports following use of Caninsulin 40 IU/ml Suspension for Injection.
Product recall for two batches of NT Labs Methylene Blue.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve ÌìÃÀÓ°Ôº, we’d like to know more about your visit today. .